What tests are used to diagnose mononucleosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Mononucleosis

The Monospot test is the recommended first-line diagnostic test for infectious mononucleosis, but when clinical suspicion remains high despite a negative result, EBV-specific serologic testing should be performed. 1

Initial Diagnostic Testing

  • The Monospot test detects heterophile antibodies that develop during EBV infection, making it a useful first-line diagnostic tool 1
  • A positive Monospot test is diagnostic for EBV infection and no further EBV-specific testing is required 1
  • False-negative Monospot results occur in approximately 10% of cases, most commonly in children younger than 10 years 1
  • False-positive results may occur in patients with leukemia, pancreatic carcinoma, viral hepatitis, or CMV infection 1

When Monospot is Negative

  • When the Monospot test is negative but clinical suspicion remains high, perform EBV-specific serologic testing using the same sample 1, 2
  • Test for IgG and IgM antibodies to viral capsid antigen (VCA) and antibodies to Epstein-Barr nuclear antigen (EBNA) 1, 3
  • Recent primary EBV infection is indicated by positive VCA IgM (with or without VCA IgG) and negative EBNA antibodies 1, 4
  • Past infection is indicated by positive VCA IgG and positive EBNA antibodies 5

Complete Diagnostic Panel

  • The most valuable serologic finding for acute infection is the presence of IgM antibody to EBV viral capsid antigen 3
  • The diagnosis of infectious mononucleosis can be made when IgG-VCA, IgM-VCA, and anti-D (early antigen) antibodies are present while EBNA antibodies are absent 4
  • EBNA antibodies appear later in the course of infection and, together with IgG-VCA antibodies, persist indefinitely 4

Blood Count Analysis

  • An atypical lymphocytosis of at least 20% or atypical lymphocytosis of at least 10% plus lymphocytosis of at least 50% strongly supports the diagnosis 6
  • However, relying solely on hematological criteria has a sensitivity of only 39%, though specificity is 99% 7

Testing for Alternative Diagnoses

  • When EBV tests are negative, consider testing for other causes of mononucleosis-like illnesses 2:
    • Cytomegalovirus (CMV)
    • Human herpesvirus 6 (HHV-6)
    • HIV
    • Adenovirus
    • Herpes simplex virus
    • Streptococcus pyogenes
    • Toxoplasma gondii

Common Pitfalls to Avoid

  • Relying solely on a negative Monospot test to rule out infectious mononucleosis, especially in children 1
  • Failing to consider EBV-specific serologic testing when clinical suspicion is high despite a negative Monospot 1
  • Not recognizing that heterophile antibodies may take time to develop, potentially requiring repeat testing 1, 7
  • Overlooking the possibility of false-negative results early in the course of infection 6

References

Guideline

Diagnostic Approach to Infectious Mononucleosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnostic evaluation of mononucleosis-like illnesses.

The American journal of medicine, 2007

Research

Diagnosis and treatment of infectious mononucleosis.

American family physician, 1994

Guideline

Epstein-Barr Virus Infection Diagnosis and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epstein-Barr virus infectious mononucleosis.

American family physician, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.